<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02110758</url>
  </required_header>
  <id_info>
    <org_study_id>IH-12-11-4383</org_study_id>
    <nct_id>NCT02110758</nct_id>
  </id_info>
  <brief_title>Evaluating the Impact of Patient-Centered Oncology Care</brief_title>
  <official_title>Evaluating the Impact of Patient-Centered Oncology Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Committee for Quality Assurance</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Society of Clinical Oncology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Independence Blue Cross</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Coalition for Cancer Survivorship</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oncology Management Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RAND</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Committee for Quality Assurance</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The National Committee for Quality Assurance has worked with the National Coalition for&#xD;
      Cancer Survivorship, the American Society of Clinical Oncology, Oncology Management Services,&#xD;
      Independence Blue Cross, and RAND, as well as a broader multi-stakeholder advisory group, to&#xD;
      define the Patient-Centered Oncology Care model. The purpose of this project was to pilot and&#xD;
      evaluate this model. Specific research questions were:&#xD;
&#xD;
        1. Does Patient-Centered Oncology Care improve patient experiences and quality of care?&#xD;
           Does it reduce undesirable events like emergency department visits and hospital stays?&#xD;
&#xD;
        2. How does adoption of Patient-Centered Oncology Care vary across a variety of practices&#xD;
           and what factors affect adoption?&#xD;
&#xD;
      The demonstration occurred in oncology practices in southeastern Pennsylvania. Practices&#xD;
      received implementation support during the 24-month demonstration period. They were evaluated&#xD;
      using patient surveys, quality measures, and measures of emergency department and hospital&#xD;
      use. Results from these practices were compared in two ways: 1) with their performance before&#xD;
      they became oncology medical homes and 2) with other similar practices.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background. Advances in cancer treatment mean that a growing number of Americans are living&#xD;
      with cancer and experiencing it as a chronic, long-term condition. National panels led by&#xD;
      consumers have identified the need for improved cancer care in the areas of communication&#xD;
      between providers and patients and their families, care planning, attention to nonmedical&#xD;
      needs, care coordination and provision of evidence-based treatment. The patient-centered&#xD;
      medical home (PCMH) model of care is being widely adopted as a way to provide accessible,&#xD;
      proactive, coordinated care and self-care through primary care practices. During active&#xD;
      treatment for cancer, the oncology practice is often the primary setting supporting the&#xD;
      patient and coordinating cancer treatment. By implementing the patient-centered medical home&#xD;
      model, an innovative oncology practice in Pennsylvania has been able to improve access and&#xD;
      reduce emergency department visits and hospitalizations for its patients.&#xD;
&#xD;
      Objectives. Building on these recommendations and experience, the National Committee for&#xD;
      Quality Assurance has worked with the National Coalition for Cancer Survivorship, the&#xD;
      American Society of Clinical Oncology, Oncology Management Services, Independence Blue Cross,&#xD;
      and RAND, as well as a broader multi-stakeholder advisory group, to define the&#xD;
      Patient-Centered Oncology Care model. We sought PCORI support to pilot and evaluate this&#xD;
      model. Specific research questions were:&#xD;
&#xD;
        1. Does Patient-Centered Oncology Care improve patient experiences and quality of care?&#xD;
           Does it reduce undesirable events like emergency department visits and hospital stays?&#xD;
&#xD;
        2. How does adoption of Patient-Centered Oncology Care vary across a variety of practices&#xD;
           and what factors affect adoption?&#xD;
&#xD;
      Methods. The demonstration occurred in 5 oncology practices in southeastern Pennsylvania.&#xD;
      Practices received implementation support during the 24-month demonstration period. They were&#xD;
      evaluated using patient surveys, quality measures, and measures of emergency department and&#xD;
      hospital use. Results from these practices were compared in two ways: 1) with their&#xD;
      performance before they became oncology medical homes and 2) with other similar practices.&#xD;
      Patients, clinicians, and health plan leaders helped design the project, and disseminate&#xD;
      results. The project used Patient Centered Outcomes Research Institute (PCORI) resources&#xD;
      efficiently by building on ongoing efforts. Our evaluation consisted of a retrospective,&#xD;
      pre-post study design with a concurrent non-randomized control group of 18 local practices&#xD;
      for the utilization and patient experience outcomes. We used difference-in-difference&#xD;
      regression models that accounted for practice-level clustering and used functional forms&#xD;
      appropriate to the dependent variables. For quality, we compared baseline and follow-up pilot&#xD;
      practice performance to national and regional benchmark performance data.&#xD;
&#xD;
      Patient Outcomes. People with cancer are seeking high quality, coordinated and supportive&#xD;
      care. The Patient-Centered Oncology Model has the potential to address current gaps in cancer&#xD;
      care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Patient Experience From Baseline to Follow up</measure>
    <time_frame>At baseline and 24 months follow up</time_frame>
    <description>Patient experience survey composite scores were evaluated in the pilot practice group and in the comparison practice group during the intervention period and the follow-up period using a modified version of the cancer CAHPS patient survey.&#xD;
We calculated survey composite scores on a 0-100 scale using proportional scoring and the summated rating method based on the CAHPS macro.This method calculates the mean responses to each survey item in the composite, after transforming each response to a 0-100 scale (100 representing the most positive response on any given item response scale; 0 representing the least positive). For example, on a Yes/No response scale, if &quot;Yes&quot; represents the most positive response, then Yes= 100 and No = 0; on an Always/Usually/Sometimes/Never response scale, if &quot;Always&quot; represents the most positive response, then Always = 100, Usually = 67, Sometimes = 33 and Never = 0. A higher score means that practices were rated more positively for care on that item.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Quality of Care From Baseline to Follow up: Percentage of Patients Receiving Recommended Care</measure>
    <time_frame>Two years prior to baseline and at 36 months follow-up</time_frame>
    <description>Quality measure performance rates were evaluated in the pilot practice group during the baseline period and the follow-up period. Data were abstracted from medical records for a sample of patients diagnosed with an invasive malignancy within previous 2 years and with at least 2 visits to the practice in the previous six months at baseline and at 36 months follow-up.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Health Care Utilization From Baseline to Follow up</measure>
    <time_frame>Two years prior to baseline and at 36 months follow up</time_frame>
    <description>Per member per month hospitalizations, emergency department visits, primary care visits and specialist visits were evaluated in the pilot group and in the comparison group using insurance claims data during the baseline, start-up, intervention and follow-up periods.</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Actual">125250</enrollment>
  <condition>Neoplasms</condition>
  <arm_group>
    <arm_group_label>Pilot Practices Patient Survey Cohort</arm_group_label>
    <description>Patients with any active drug therapy treatment for cancer receiving care at pilot practice in southeastern Pennsylvania</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparison Practices Patient Survey Cohort</arm_group_label>
    <description>Patients with any active drug therapy treatment for cancer receiving care at comparison practice in southeastern Pennsylvania</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pilot Practices Utilization Cohort</arm_group_label>
    <description>Patients with an evaluation &amp; management claim attributed to a medical oncology pilot practice in southeastern Pennsylvania</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparison Practices Utilization Cohort</arm_group_label>
    <description>Patients with an evaluation &amp; management claim attributed to a medical oncology comparison practice in southeastern Pennsylvania</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pilot Practices Quality Measures Cohort</arm_group_label>
    <description>Patients with a new diagnosis of cancer in the past two years</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pilot of Patient-Centered Oncology Care</intervention_name>
    <description>Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
    <arm_group_label>Pilot Practices Patient Survey Cohort</arm_group_label>
    <arm_group_label>Pilot Practices Quality Measures Cohort</arm_group_label>
    <arm_group_label>Pilot Practices Utilization Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consisted of patients with cancer who received their cancer care from&#xD;
        oncology practices. We attributed patients to the study practices (pilot or comparison&#xD;
        practices) based on the plurality of office visits for cancer diagnoses. We used&#xD;
        sensitivity analyses to investigate other attribution rules, such as the majority of such&#xD;
        office visits.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  Diagnosis of cancer&#xD;
&#xD;
          -  Receives care at a pilot or comparison oncology practice located in southeastern&#xD;
             Pennsylvania that accepts patients with Independence Blue Cross health insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any person that does not meet any of the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah H Scholle, DrPH, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Committee for Quality Assurance</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Committee for Quality Assurance</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 31, 2014</study_first_submitted>
  <study_first_submitted_qc>April 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2014</study_first_posted>
  <results_first_submitted>August 21, 2017</results_first_submitted>
  <results_first_submitted_qc>March 5, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 9, 2021</results_first_posted>
  <last_update_submitted>March 5, 2021</last_update_submitted>
  <last_update_submitted_qc>March 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Patient Care Management</keyword>
  <keyword>Patient Care Planning</keyword>
  <keyword>Patient-Centered Care</keyword>
  <keyword>Patient Care Team</keyword>
  <keyword>Advance Care Planning</keyword>
  <keyword>Delivery of Health Care</keyword>
  <keyword>Evidence-based Practice</keyword>
  <keyword>Health Care Costs</keyword>
  <keyword>Health Care Quality, Access, and Evaluation</keyword>
  <keyword>Quality of Health Care</keyword>
  <keyword>Neoplasms</keyword>
  <keyword>Medical Oncology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>We didn't follow patients longitudinally. We analyzed cross-sectional patient samples across our pilot and comparison arms in four different time periods: baseline, start-up, intervention &amp; follow-up. Adding up the cross-sectional samples across the periods and arms equals our total enrollment of 125,250 patients.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Pilot Practices Patient Survey Cohort</title>
          <description>Patients with any active drug therapy treatment for cancer receiving care at pilot practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
        </group>
        <group group_id="P2">
          <title>Comparison Practices Patient Survey Cohort</title>
          <description>Patients with any active drug therapy treatment for cancer receiving care at comparison practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
No intervention/Usual care</description>
        </group>
        <group group_id="P3">
          <title>Pilot Practices Utilization Cohort</title>
          <description>Patients with an evaluation &amp; management claim attributed to a medical oncology pilot practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
        </group>
        <group group_id="P4">
          <title>Comparison Practices Utilization Cohort</title>
          <description>Patients with an evaluation &amp; management claim attributed to a medical oncology comparison practice in southeastern Pennsylvania&#xD;
Intervention: No intervention/Usual care</description>
        </group>
        <group group_id="P5">
          <title>Pilot Practices Quality Measures Cohort</title>
          <description>Patients with a new diagnosis of cancer in the past two years&#xD;
Intervention:&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Baseline: August 2011-July 2013</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="9832"/>
                <participants group_id="P4" count="18994"/>
                <participants group_id="P5" count="308"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="9832"/>
                <participants group_id="P4" count="18994"/>
                <participants group_id="P5" count="308"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Start-Up: August 2013-June 2014</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="175"/>
                <participants group_id="P2" count="431"/>
                <participants group_id="P3" count="8057"/>
                <participants group_id="P4" count="12883"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="175"/>
                <participants group_id="P2" count="431"/>
                <participants group_id="P3" count="8057"/>
                <participants group_id="P4" count="12883"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Intervention: July 2014-December 2015</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="10106"/>
                <participants group_id="P4" count="33012"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="10106"/>
                <participants group_id="P4" count="33012"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Follow-Up: January-July 2016</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="81"/>
                <participants group_id="P2" count="179"/>
                <participants group_id="P3" count="6451"/>
                <participants group_id="P4" count="24392"/>
                <participants group_id="P5" count="349"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="81"/>
                <participants group_id="P2" count="179"/>
                <participants group_id="P3" count="6451"/>
                <participants group_id="P4" count="24392"/>
                <participants group_id="P5" count="349"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pilot Practices Patient Survey Cohort</title>
          <description>Patients with any active drug therapy treatment for cancer receiving care at pilot practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
        </group>
        <group group_id="B2">
          <title>Comparison Practices Patient Survey Cohort</title>
          <description>Patients with any active drug therapy treatment for cancer receiving care at comparison practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
No intervention/Usual care</description>
        </group>
        <group group_id="B3">
          <title>Pilot Practices Utilization Cohort</title>
          <description>Patients with any active drug therapy treatment for cancer receiving care at pilot practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
        </group>
        <group group_id="B4">
          <title>Comparison Practices Utilization Cohort</title>
          <description>Patients with any active drug therapy treatment for cancer receiving care at comparison practice in southeastern Pennsylvania&#xD;
Intervention: No intervention/Usual care</description>
        </group>
        <group group_id="B5">
          <title>Pilot Practices Quality Measures Cohort</title>
          <description>Patients with a new diagnosis of cancer in the past two years&#xD;
Intervention:&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="256"/>
            <count group_id="B2" value="610"/>
            <count group_id="B3" value="34446"/>
            <count group_id="B4" value="89281"/>
            <count group_id="B5" value="657"/>
            <count group_id="B6" value="125250"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>18-24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="344"/>
                    <measurement group_id="B4" value="894"/>
                    <measurement group_id="B5" value="18"/>
                    <measurement group_id="B6" value="1256"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25-54</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="108"/>
                    <measurement group_id="B3" value="11385"/>
                    <measurement group_id="B4" value="29812"/>
                    <measurement group_id="B5" value="173"/>
                    <measurement group_id="B6" value="41514"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>55-64</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="177"/>
                    <measurement group_id="B3" value="10564"/>
                    <measurement group_id="B4" value="26761"/>
                    <measurement group_id="B5" value="180"/>
                    <measurement group_id="B6" value="37765"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>65-74</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="141"/>
                    <measurement group_id="B3" value="5693"/>
                    <measurement group_id="B4" value="14116"/>
                    <measurement group_id="B5" value="183"/>
                    <measurement group_id="B6" value="20198"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75 and older</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="169"/>
                    <measurement group_id="B3" value="6460"/>
                    <measurement group_id="B4" value="17698"/>
                    <measurement group_id="B5" value="103"/>
                    <measurement group_id="B6" value="24494"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="153"/>
                    <measurement group_id="B2" value="386"/>
                    <measurement group_id="B3" value="22004"/>
                    <measurement group_id="B4" value="59168"/>
                    <measurement group_id="B5" value="338"/>
                    <measurement group_id="B6" value="82049"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="95"/>
                    <measurement group_id="B2" value="209"/>
                    <measurement group_id="B3" value="11992"/>
                    <measurement group_id="B4" value="30113"/>
                    <measurement group_id="B5" value="319"/>
                    <measurement group_id="B6" value="42728"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="137"/>
                    <measurement group_id="B2" value="368"/>
                    <measurement group_id="B3" value="24571"/>
                    <measurement group_id="B4" value="69766"/>
                    <measurement group_id="B5" value="416"/>
                    <measurement group_id="B6" value="95258"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black/African-American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="6025"/>
                    <measurement group_id="B4" value="12117"/>
                    <measurement group_id="B5" value="57"/>
                    <measurement group_id="B6" value="18254"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>American Indian/Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian/Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic/Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="14"/>
                    <measurement group_id="B6" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="3400"/>
                    <measurement group_id="B4" value="89281"/>
                    <measurement group_id="B5" value="154"/>
                    <measurement group_id="B6" value="93110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="256"/>
                    <measurement group_id="B2" value="610"/>
                    <measurement group_id="B3" value="33996"/>
                    <measurement group_id="B4" value="89281"/>
                    <measurement group_id="B5" value="657"/>
                    <measurement group_id="B6" value="65743"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Patient Experience From Baseline to Follow up</title>
        <description>Patient experience survey composite scores were evaluated in the pilot practice group and in the comparison practice group during the intervention period and the follow-up period using a modified version of the cancer CAHPS patient survey.&#xD;
We calculated survey composite scores on a 0-100 scale using proportional scoring and the summated rating method based on the CAHPS macro.This method calculates the mean responses to each survey item in the composite, after transforming each response to a 0-100 scale (100 representing the most positive response on any given item response scale; 0 representing the least positive). For example, on a Yes/No response scale, if &quot;Yes&quot; represents the most positive response, then Yes= 100 and No = 0; on an Always/Usually/Sometimes/Never response scale, if &quot;Always&quot; represents the most positive response, then Always = 100, Usually = 67, Sometimes = 33 and Never = 0. A higher score means that practices were rated more positively for care on that item.</description>
        <time_frame>At baseline and 24 months follow up</time_frame>
        <population>Only the Pilot Practices Patient Survey Cohort and Comparison Practices Patient Survey Cohort were pre-specified to be assessed for this Primary Outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Pilot Practices Patient Survey Cohort</title>
            <description>Patients with any active drug therapy treatment for cancer receiving care at pilot practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
          </group>
          <group group_id="O2">
            <title>Comparison Practices Patient Survey Cohort</title>
            <description>Patients with any active drug therapy treatment for cancer receiving care at comparison practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
No intervention/Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Patient Experience From Baseline to Follow up</title>
          <description>Patient experience survey composite scores were evaluated in the pilot practice group and in the comparison practice group during the intervention period and the follow-up period using a modified version of the cancer CAHPS patient survey.&#xD;
We calculated survey composite scores on a 0-100 scale using proportional scoring and the summated rating method based on the CAHPS macro.This method calculates the mean responses to each survey item in the composite, after transforming each response to a 0-100 scale (100 representing the most positive response on any given item response scale; 0 representing the least positive). For example, on a Yes/No response scale, if &quot;Yes&quot; represents the most positive response, then Yes= 100 and No = 0; on an Always/Usually/Sometimes/Never response scale, if &quot;Always&quot; represents the most positive response, then Always = 100, Usually = 67, Sometimes = 33 and Never = 0. A higher score means that practices were rated more positively for care on that item.</description>
          <population>Only the Pilot Practices Patient Survey Cohort and Comparison Practices Patient Survey Cohort were pre-specified to be assessed for this Primary Outcome.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="256"/>
                <count group_id="O2" value="610"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Affective Communication Composite-Start-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="175"/>
                    <count group_id="O2" value="431"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.1" lower_limit="87.9" upper_limit="99.2"/>
                    <measurement group_id="O2" value="90.0" lower_limit="85.7" upper_limit="98.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Affective Communication Composite-Follow-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="81"/>
                    <count group_id="O2" value="179"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.8" lower_limit="82.1" upper_limit="97.4"/>
                    <measurement group_id="O2" value="92.4" lower_limit="63.5" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Access Composite-Start-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="175"/>
                    <count group_id="O2" value="431"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" lower_limit="90.6" upper_limit="98.9"/>
                    <measurement group_id="O2" value="91.0" lower_limit="79.8" upper_limit="99.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Access Composite-Follow-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="81"/>
                    <count group_id="O2" value="179"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.4" lower_limit="83.4" upper_limit="94.4"/>
                    <measurement group_id="O2" value="93.6" lower_limit="78.6" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Exchanging Information Composite-Start-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="175"/>
                    <count group_id="O2" value="431"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.1" lower_limit="83.8" upper_limit="97.5"/>
                    <measurement group_id="O2" value="89.1" lower_limit="77.8" upper_limit="98.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Exchanging Information Composite-Follow-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="81"/>
                    <count group_id="O2" value="179"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.0" lower_limit="84.2" upper_limit="91.1"/>
                    <measurement group_id="O2" value="89.8" lower_limit="53.9" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patient Self-Management Composite-Start-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="175"/>
                    <count group_id="O2" value="431"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.2" lower_limit="68.5" upper_limit="86.5"/>
                    <measurement group_id="O2" value="76.3" lower_limit="20.6" upper_limit="88.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patient Self-Management Composite-Follow-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="81"/>
                    <count group_id="O2" value="179"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.9" lower_limit="59.5" upper_limit="74.9"/>
                    <measurement group_id="O2" value="68.3" lower_limit="36.6" upper_limit="80.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Shared Decision-Making Composite-Start-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="175"/>
                    <count group_id="O2" value="431"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.6" lower_limit="58.7" upper_limit="94.5"/>
                    <measurement group_id="O2" value="77.9" lower_limit="41.4" upper_limit="95.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Shared Decision-Making Composite-Follow-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="81"/>
                    <count group_id="O2" value="179"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.3" lower_limit="80.1" upper_limit="87.8"/>
                    <measurement group_id="O2" value="79.7" lower_limit="59.3" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall Rating-Start-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="175"/>
                    <count group_id="O2" value="431"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.9" lower_limit="92.4" upper_limit="99"/>
                    <measurement group_id="O2" value="90.1" lower_limit="76.2" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall Rating-Follow-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="81"/>
                    <count group_id="O2" value="179"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.8" lower_limit="82.1" upper_limit="97.4"/>
                    <measurement group_id="O2" value="94.2" lower_limit="64.5" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To estimate exposure to the intervention on the Access composite score, we used a difference-in-differences model with fixed effects for practices. The dependent variable was the composite score. The intervention effects were represented by the coefficient estimates for survey time period (pre or post) interacted with status (pilot or comparison).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>.025</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To estimate exposure to the intervention on the Affective Communication composite score, we used a difference-in-differences model with fixed effects for practices. The dependent variable was the composite score. The intervention effects were represented by the coefficient estimates for survey time period (pre or post) interacted with status (pilot or comparison).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.69</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To estimate exposure to the intervention on the Shared Decision-Making composite score, we used a difference-in-differences model with fixed effects for practices. The dependent variable was the composite score. The intervention effects were represented by the coefficient estimates for survey time period (pre or post) interacted with status (pilot or comparison).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>.013</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To estimate exposure to the intervention on the Patient Self-Management composite score, we used a difference-in-differences model with fixed effects for practices. The dependent variable was the composite score. The intervention effects were represented by the coefficient estimates for survey time period (pre or post) interacted with status (pilot or comparison).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.85</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To estimate exposure to the intervention on the Exchanging Information composite score, we used a difference-in-differences model with fixed effects for practices. The dependent variable was the composite score. The intervention effects were represented by the coefficient estimates for survey time period (pre or post) interacted with status (pilot or comparison).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>.013</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To estimate exposure to the intervention on the Overall Rating of Treatment Team composite score, we used a difference-in-differences model with fixed effects for practices. The dependent variable was the composite score. The intervention effects were represented by the coefficient estimates for survey time period (pre or post) interacted with status (pilot or comparison).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>.053</p_value>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Quality of Care From Baseline to Follow up: Percentage of Patients Receiving Recommended Care</title>
        <description>Quality measure performance rates were evaluated in the pilot practice group during the baseline period and the follow-up period. Data were abstracted from medical records for a sample of patients diagnosed with an invasive malignancy within previous 2 years and with at least 2 visits to the practice in the previous six months at baseline and at 36 months follow-up.</description>
        <time_frame>Two years prior to baseline and at 36 months follow-up</time_frame>
        <population>The pilot practices quality measures cohort were pre-specified to be assessed for this outcome. The pilot practices pulled a sample of patient charts at baseline and follow-up (total of 657 patients). Some patients were eligible for specific measures below and some were not.</population>
        <group_list>
          <group group_id="O1">
            <title>Pilot Practices Quality Measures Cohort</title>
            <description>Patients with a new diagnosis of cancer in the past two years&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Quality of Care From Baseline to Follow up: Percentage of Patients Receiving Recommended Care</title>
          <description>Quality measure performance rates were evaluated in the pilot practice group during the baseline period and the follow-up period. Data were abstracted from medical records for a sample of patients diagnosed with an invasive malignancy within previous 2 years and with at least 2 visits to the practice in the previous six months at baseline and at 36 months follow-up.</description>
          <population>The pilot practices quality measures cohort were pre-specified to be assessed for this outcome. The pilot practices pulled a sample of patient charts at baseline and follow-up (total of 657 patients). Some patients were eligible for specific measures below and some were not.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="657"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain assessed, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain assessed, Follow-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="349"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain intensity quantified, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="235"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain intensity quantified, Follow-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="329"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plan of care for moderate/severe pain, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plan of care for moderate/severe pain, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="61"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain addressed defect-free measure, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain addressed defect-free measure, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="349"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional well-being assessed, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="266"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional well-being assessed, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="349"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional well-being addressed, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional well-being addressed, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Documented plan for chemotherapy, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="278"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Documented plan for chemotherapy, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="290"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy intent documented, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="276"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy intent documented, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="290"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy intent discussion w/ patient, Baselil</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="277"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy intent discussion with patient, follo</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="290"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of chemotherapy cycles documented, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of chemotherapy cycles documented, Follow-u</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy planning defect-free measur, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="276"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy planning defect-free measu, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="290"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy treatment summary completed, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="259"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy treatment summary completed, Follow-u</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy treatment summary to patient, Baselin</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="255"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy treatment summary to patient, Follow-</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy treatment summary to provider, Basel</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="256"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy treatment summary to provider, Follow</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy treatment defect-free measur Baselin</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemotherapy treatment defect-free measur Follow-u</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tobacco use documented, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="298"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tobacco use documented, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="343"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tobacco use cessation recommended, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tobacco use cessation recommended, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tobacco use cessation administered, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tobacco use cessation administered, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tobacco defect-free measure, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="298"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tobacco defect-free measure, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="343"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serotonin antagonist prescribed, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="97"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serotonin antagonist prescribed, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sertonin antagonist/corticosteroids, Ba</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="215"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serotonin antagonist/corticosteroids, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="228"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aprepitant prescribed, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="101"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aprepitant prescribed, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="72"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anti-emetics defect-free measure, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anti-emetics defect-free measure, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infertility risks discussed, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infertility risks discussed, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fertility preservation options discussed, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fertility preservation options discussed, Follow-u</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Health Care Utilization From Baseline to Follow up</title>
        <description>Per member per month hospitalizations, emergency department visits, primary care visits and specialist visits were evaluated in the pilot group and in the comparison group using insurance claims data during the baseline, start-up, intervention and follow-up periods.</description>
        <time_frame>Two years prior to baseline and at 36 months follow up</time_frame>
        <population>Only the Pilot Practices Utilization Cohort and Comparison Practices Utilization Cohort were pre-specified to be assessed for this outcome</population>
        <group_list>
          <group group_id="O1">
            <title>Pilot Practices Utilization Cohort</title>
            <description>Patients with an evaluation &amp; management claim attributed to a medical oncology pilot practice in southeastern Pennsylvania&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
          </group>
          <group group_id="O2">
            <title>Comparison Practices Utilization Cohort</title>
            <description>Patients with an evaluation &amp; management claim attributed to a medical oncology comparison practice in southeastern Pennsylvania</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Health Care Utilization From Baseline to Follow up</title>
          <description>Per member per month hospitalizations, emergency department visits, primary care visits and specialist visits were evaluated in the pilot group and in the comparison group using insurance claims data during the baseline, start-up, intervention and follow-up periods.</description>
          <population>Only the Pilot Practices Utilization Cohort and Comparison Practices Utilization Cohort were pre-specified to be assessed for this outcome</population>
          <units>Per member per month visits</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34446"/>
                <count group_id="O2" value="89281"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All-cause hospitalizations, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9832"/>
                    <count group_id="O2" value="18994"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0403" lower_limit="0" upper_limit="0.8750"/>
                    <measurement group_id="O2" value="0.0386" lower_limit="0" upper_limit="1.3333"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All-cause hospitalizations, Start-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8057"/>
                    <count group_id="O2" value="12883"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0484" lower_limit="0" upper_limit="1.6364"/>
                    <measurement group_id="O2" value="0.0823" lower_limit="0" upper_limit="1.7273"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All-cause hospitalizations, Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10106"/>
                    <count group_id="O2" value="33012"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0623" lower_limit="0" upper_limit="1.3333"/>
                    <measurement group_id="O2" value="0.0512" lower_limit="0" upper_limit="1.1667"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All-cause hospitalizations, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6451"/>
                    <count group_id="O2" value="24392"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0574" lower_limit="0" upper_limit="1.7143"/>
                    <measurement group_id="O2" value="0.0529" lower_limit="0" upper_limit="2.2857"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All-cause ED visits, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9832"/>
                    <count group_id="O2" value="18994"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0815" lower_limit="0" upper_limit="2.6667"/>
                    <measurement group_id="O2" value="0.0781" lower_limit="0" upper_limit="4.1667"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All-cause ED visits, Start-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8057"/>
                    <count group_id="O2" value="12883"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0873" lower_limit="0" upper_limit="4.6364"/>
                    <measurement group_id="O2" value="0.0973" lower_limit="0" upper_limit="6.0000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All-cause ED visits, Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10106"/>
                    <count group_id="O2" value="33012"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0825" lower_limit="0" upper_limit="9.5556"/>
                    <measurement group_id="O2" value="0.0833" lower_limit="0" upper_limit="3.2778"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All-cause ED Visits, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6451"/>
                    <count group_id="O2" value="24392"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0969" lower_limit="0" upper_limit="3.8571"/>
                    <measurement group_id="O2" value="0.1008" lower_limit="0" upper_limit="4.2857"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PCP Office Visits, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9832"/>
                    <count group_id="O2" value="18994"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2539" lower_limit="0" upper_limit="3.5417"/>
                    <measurement group_id="O2" value="0.2505" lower_limit="0" upper_limit="5.0417"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PCP Office Visits, Start-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8057"/>
                    <count group_id="O2" value="12883"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2657" lower_limit="0" upper_limit="10.909"/>
                    <measurement group_id="O2" value="0.2679" lower_limit="0" upper_limit="8.6364"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PCP Office Visits, Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10106"/>
                    <count group_id="O2" value="33012"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2764" lower_limit="0" upper_limit="5.0556"/>
                    <measurement group_id="O2" value="0.2781" lower_limit="0" upper_limit="12.889"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PCP Office Visits, Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6451"/>
                    <count group_id="O2" value="24392"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2731" lower_limit="0" upper_limit="4.4286"/>
                    <measurement group_id="O2" value="0.2731" lower_limit="0" upper_limit="11.857"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specialist Office Visits, Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9832"/>
                    <count group_id="O2" value="18994"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9211" lower_limit="0" upper_limit="18.208"/>
                    <measurement group_id="O2" value="0.8967" lower_limit="0" upper_limit="8.7083"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specialist Office Visits, Start-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8057"/>
                    <count group_id="O2" value="12883"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9211" lower_limit="0" upper_limit="18.208"/>
                    <measurement group_id="O2" value="0.8967" lower_limit="0" upper_limit="8.7083"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specialist Office Visits, Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10106"/>
                    <count group_id="O2" value="33012"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0199" lower_limit="0" upper_limit="16.545"/>
                    <measurement group_id="O2" value="1.0141" lower_limit="0" upper_limit="17.636"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specialist Office Visits, Follow-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6451"/>
                    <count group_id="O2" value="24392"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0018" lower_limit="0" upper_limit="10.167"/>
                    <measurement group_id="O2" value="0.9549" lower_limit="0" upper_limit="11.111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To estimate exposure to the intervention on Per Member Per Month Hospitalizations, we used a difference-in-differences model with fixed effects for practices. The dependent variable was Per Member Per Month Hospitalizations. The intervention effects were represented by the coefficient estimates for utilization time period (baseline or follow-up) interacted with status (pilot or comparison).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.2</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To estimate exposure to the intervention on Per Member Per Month Emergency Department (ED) Visits, we used a difference-in-differences model with fixed effects for practices. The dependent variable was Per Member Per Month ED Visits. The intervention effects were represented by the coefficient estimates for utilization time period (baseline or follow-up) interacted with status (pilot or comparison).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.62</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To estimate exposure to the intervention on Per Member Per Month Primary Care Visits, we used a difference-in-differences model with fixed effects for practices. The dependent variable was Per Member Per Month Primary Care Visits. The intervention effects were represented by the coefficient estimates for utilization time period (baseline or follow-up) interacted with status (pilot or comparison).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.68</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To estimate exposure to the intervention on Per Member Per Month Specialist Visits, we used a difference-in-differences model with fixed effects for practices. The dependent variable was Per Member Per Month Specialist Visits. The intervention effects were represented by the coefficient estimates for utilization time period (baseline or follow-up) interacted with status (pilot or comparison).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>All-Cause Mortality, Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed</desc>
      <group_list>
        <group group_id="E1">
          <title>Pilot Practices Patient Survey Cohort</title>
          <description>Patients with any active drug therapy treatment for cancer receiving care at pilot practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
        </group>
        <group group_id="E2">
          <title>Comparison Practices Patient Survey Cohort</title>
          <description>Patients with any active drug therapy treatment for cancer receiving care at comparison practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
No intervention/Usual care</description>
        </group>
        <group group_id="E3">
          <title>Pilot Practices Utilization Cohort</title>
          <description>Patients with any active drug therapy treatment for cancer receiving care at pilot practice in southeastern Pennsylvania&#xD;
Intervention:&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
        </group>
        <group group_id="E4">
          <title>Comparison Practices Utilization Cohort</title>
          <description>Patients with any active drug therapy treatment for cancer receiving care at comparison practice in southeastern Pennsylvania&#xD;
Intervention: No intervention/Usual care</description>
        </group>
        <group group_id="E5">
          <title>Pilot Practices Quality Measures Cohort</title>
          <description>Patients with a new diagnosis of cancer in the past two years&#xD;
Intervention:&#xD;
Patient-Centered Oncology Care: Patient-Centered Oncology Care addresses six domains: track &amp; coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track &amp; coordinate care, and measure and improve performance.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sarah Hudson Scholle</name_or_title>
      <organization>National Committee for Quality Assurance</organization>
      <phone>202-955-1726</phone>
      <email>scholle@ncqa.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

